On-Demand CME Videos
The Many Shades of Plaque Psoriasis: Considerations for Treating Skin of Color
About
This activity was recorded at the Fall Clinical Dermatology Conference 2023.
The Many Shades of Plaque Psoriasis: Considerations for Treating Skin of Color
This activity is supported by educational grants from Bristol Myers Squibb and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
December 5, 2023
December 31, 2024
Learning Objectives
At the completion of this activity, participants should be better able to:
Highlight the key different clinical presentations of plaque psoriasis in skin of color (SOC)
Review the unique treatment goals in patients with SOC that have psoriasis
Classify the role of novel targeted agents for the management of plaque psoriasis in SOC
Intended Audience
Faculty
Andrew Alexis, MD, MPH
Vice-Chair for Diversity and Inclusion, Dept. of Dermatology
Professor of Clinical Dermatology
Weill Cornell Medicine
New York, NY
Mona Shahriari, MD
Dermatologist, Yale University School of Medicine
Central CT Dermatology
Cromwell, CT
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: BMS, LEO, Novartis, Almirall
Consultant: Leo, Galderma, Pfizer, Sanofi- Regeneron
Speakers’ Bureau or Honoraria: Regeneron, SANOFI-Genzyme, Pfizer, BMS
Grant/Research Support: AbbVie, Dermira, Cara, Dermavant, Novartis, Union
Consultant: Abbvie, BMS, Dermavant, Leo, Lilly, Sanofi, Regeneron, UCB
Speakers’ Bureau or Honoraria: Abbvie, BMS, Lilly, Leo, Janssen, Dermavant
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.